Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $66.27 USD
Change Today -1.10 / -1.63%
Volume 466.4K
IART On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
NASDAQ GS
As of 4:30 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

integra lifesciences holding (IART) Snapshot

Open
$67.43
Previous Close
$67.37
Day High
$68.46
Day Low
$66.02
52 Week High
06/23/15 - $70.32
52 Week Low
07/10/14 - $45.07
Market Cap
2.2B
Average Volume 10 Days
370.3K
EPS TTM
$2.30
Shares Outstanding
32.9M
EX-Date
--
P/E TM
28.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for INTEGRA LIFESCIENCES HOLDING (IART)

Related News

No related news articles were found.

integra lifesciences holding (IART) Related Businessweek News

No Related Businessweek News Found

integra lifesciences holding (IART) Details

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery; U.S. Extremities; U.S. Instruments; U.S. Spine and Other; and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. In addition, it provides extremity products, including bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist and shoulder arthroplasty, carpal tunnel syndrome, and cubital tunnel syndrome, as well as regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes. Further, the company offers instruments products, such as specialty and general surgical and dental instruments; and surgical lighting for hospitals, outpatient surgery centers, and physician, veterinarian, and dental practices. Integra LifeSciences Holdings Corporation sells its products directly through various sales forces and other distribution channels in the United States and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.

3,400 Employees
Last Reported Date: 02/27/15
Founded in 1989

integra lifesciences holding (IART) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $827.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $537.3K
President of Specialty Surgical Solutions and...
Total Annual Compensation: $344.7K
Corporate Vice President, General Counsel, Ad...
Total Annual Compensation: $364.2K
Corporate Vice President of Global Operations...
Total Annual Compensation: $363.0K
Compensation as of Fiscal Year 2014.

integra lifesciences holding (IART) Key Developments

Integra LifeSciences Seeks Acquisitions

Integra LifeSciences Holdings Corporation (NasdaqGS:IART) is looking for acquisition opportunities. Integra LifeSciences strategically targeted acquisitions will be accretive to the company's outlook as it augments its market positions.

Integra LifeSciences Holdings Corporation, TEI Biosciences Inc., TEI Medical Inc. - M&A Call

To discuss definitive agreement under which Integra will acquire all of the outstanding shares of TEI Biosciences, Inc. and TEI Medical, Inc

Integra LifeSciences Holdings Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 04:00 PM

Integra LifeSciences Holdings Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 04:00 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Peter J. Arduini, Chief Executive Officer, President, Director and Member of Special Award Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IART:US $66.27 USD -1.10

IART Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $132.93 USD +1.83
Globus Medical Inc $25.83 USD +0.16
Masimo Corp $38.77 USD +0.03
NuVasive Inc $47.52 USD +0.14
Medicines Co/The $28.34 USD -0.27
View Industry Companies
 

Industry Analysis

IART

Industry Average

Valuation IART Industry Range
Price/Earnings 55.5x
Price/Sales 2.3x
Price/Book 3.2x
Price/Cash Flow 42.1x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTEGRA LIFESCIENCES HOLDING, please visit www.integralife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.